85 related articles for article (PubMed ID: 11249822)
1. Mechanisms responsible for cross-resistance and dichotomous resistance among the quinolones.
Sanders CC
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S1-8. PubMed ID: 11249822
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
Ruiz J
J Antimicrob Chemother; 2003 May; 51(5):1109-17. PubMed ID: 12697644
[TBL] [Abstract][Full Text] [Related]
3. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
Roychoudhury S; Catrenich CE; McIntosh EJ; McKeever HD; Makin KM; Koenigs PM; Ledoussal B
Antimicrob Agents Chemother; 2001 Apr; 45(4):1115-20. PubMed ID: 11257024
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of bacterial resistance to quinolones].
Taléns-Visconti R; Garrigues TM; Cantón E
Rev Esp Quimioter; 2002 Mar; 15(1):25-31. PubMed ID: 12582434
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to quinolones.
Jacoby GA
Clin Infect Dis; 2005 Jul; 41 Suppl 2():S120-6. PubMed ID: 15942878
[TBL] [Abstract][Full Text] [Related]
6. Quinolone resistance mechanisms in pneumococci.
Eliopoulos GM
Clin Infect Dis; 2004 May; 38 Suppl 4():S350-6. PubMed ID: 15127369
[TBL] [Abstract][Full Text] [Related]
7. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
McIver C; Hogan T; White P; Tapsall J
Pathology; 2004 Apr; 36(2):166-9. PubMed ID: 15203753
[TBL] [Abstract][Full Text] [Related]
8. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.
Schmitz FJ; Higgins PG; Mayer S; Fluit AC; Dalhoff A
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):647-59. PubMed ID: 12373497
[TBL] [Abstract][Full Text] [Related]
9. Quinolones in 2005: an update.
Van Bambeke F; Michot JM; Van Eldere J; Tulkens PM
Clin Microbiol Infect; 2005 Apr; 11(4):256-80. PubMed ID: 15760423
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of action of antimicrobials: focus on fluoroquinolones.
Hooper DC
Clin Infect Dis; 2001 Mar; 32 Suppl 1():S9-S15. PubMed ID: 11249823
[TBL] [Abstract][Full Text] [Related]
11. Resistance in gram-negative bacteria: enterobacteriaceae.
Paterson DL
Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
[TBL] [Abstract][Full Text] [Related]
12. [Quinolones and Streptococcus pneumoniae. Mechanisms of action and resistance].
Taléns-Visconti R; Garrigues TM; Cantón E
Rev Esp Quimioter; 2002 Dec; 15(4):313-24. PubMed ID: 12587036
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of quinolone resistance in Salmonella.
Cloeckaert A; Chaslus-Dancla E
Vet Res; 2001; 32(3-4):291-300. PubMed ID: 11432420
[TBL] [Abstract][Full Text] [Related]
14. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Kugelberg E; Löfmark S; Wretlind B; Andersson DI
J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates.
Capilla S; Ruiz J; Goñi P; Castillo J; Rubio MC; Jiménez de Anta MT; Gómez-Lus R; Vila J
J Antimicrob Chemother; 2004 Jun; 53(6):1068-71. PubMed ID: 15117921
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of quinolone action and microbial response.
Hawkey PM
J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
[TBL] [Abstract][Full Text] [Related]
18. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations.
Avrain L; Garvey M; Mesaros N; Glupczynski Y; Mingeot-Leclercq MP; Piddock LJ; Tulkens PM; Vanhoof R; Van Bambeke F
J Antimicrob Chemother; 2007 Nov; 60(5):965-72. PubMed ID: 17693451
[TBL] [Abstract][Full Text] [Related]
19. Vibrio parahaemolyticus chromosomal qnr homologue VPA0095: demonstration by transformation with a mutated gene of its potential to reduce quinolone susceptibility in Escherichia coli.
Saga T; Kaku M; Onodera Y; Yamachika S; Sato K; Takase H
Antimicrob Agents Chemother; 2005 May; 49(5):2144-5. PubMed ID: 15855551
[No Abstract] [Full Text] [Related]
20. Plasmid-mediated quinolone resistance.
Martínez-Martínez L; Eliecer Cano M; Manuel Rodríguez-Martínez J; Calvo J; Pascual A
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):685-711. PubMed ID: 18847406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
